Clinical Trial Update: A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sintilimab or placebo plus chemotherapy as second-line treatment for stage IV nonsquamous non-small cell lung cancer with wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonsquamous Non-small Cell Lung Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Xin-Hua Xu | Conditions: Nonsquamous Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN